Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
MGC Pharmaceuticals Limited · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Jun 2026 | $26.38M | $26.38M - $26.38M | -$26.38M | -$21.805 | 1 |
| Jun 2025 | $20.82M | $20.82M - $20.82M | -$20.82M | -$43.61 | 1 |
| Jun 2024 | $12.80M | $12.80M - $12.80M | -$12.80M | -$68.906 | 1 |
| Jun 2023 | $4.08M | $4.08M - $4.08M | -$4.08M | -$5.603 | 1 |
| Jun 2022 | $9.87M | $9.87M - $9.87M | -$9.87M | -$3.70 | 1 |
| Jun 2021 | $2.68M | $2.68M - $2.68M | -$2.68M | -$5.599 | 1 |
| Jun 2020 | $2.42M | $2.42M - $2.42M | -$2.42M | -$5.911 | 1 |
| Jun 2019 | $1.44M | $1.44M - $1.44M | -$1.44M | -$4.099 | 1 |
| Jun 2018 | $298.0K | $298.0K - $298.0K | -$298.0K | -$6.989 | 1 |